Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
Hark announced that it will launch a six-week tour of the Southeast beginning in July in partnership with Bespoke Video Production of Little Rock.
Nancy Gray, the new director of the BioVentures business incubator at the University of Arkansas for Medical Sciences in Little Rock, is developing an entrepreneur-in-residence program to help mentor potential startup founders at the school.
Northwest Arkansas isn’t California’s Silicon Valley and has a long way to go before it can be considered remotely comparable, but technology industry leaders say the area is proving to be on the short list of best places in the field.
Wal-Mart needs vast numbers of technologically advanced workers and needs them as soon as possible, says SVP Rick Webb.